BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2001

View Archived Issues

Recombinant hGH approved in E.U. for Turner's syndrome

Read More

BioMarin exercises option to product candidate for burns and wounds

Read More

Phogen and Atugen combine technologies in new alliance

Read More

Medarex and B. Twelve to develop human antibody therapeutics for cancer

Read More

Cellegy accelerates U.S. filing for Anogesic

Read More

Two new antiasthmatic compounds included in Inflazyme/Aventis alliance

Read More

Grant for paraoxonase research awarded to U. Michigan and Esperion

Read More

Binding and functional activity of the first truly selective alpha1A antagonist characterized

Read More

Scotia's Foscan receives negative opinion from EMEA

Read More

Roche highlights recent achievements in Japan

Read More

Dutch group identifies novel classes of adenosine receptor antagonists

Read More

Phytera achieves research milestone in antifungal drug collaboration with Lilly

Read More

Herbal remedy as a therapeutic option in premenstrual syndrome

Read More

Alista enters phase II evaluation for FSD

Read More

Second milestone achieved in Cubist/Novartis antiinfective alliance

Read More

NicOx's HCT-3012 moves into phase II clinical trials in Europe and the U.S.

Read More

Molecular mechanisms of antidiabetic and antiobesity effects of AJ-9677

Read More

Pexelizumab has a significant impact on outcome of CABG patients in phase II

Read More

CeNeS to market Xefo in the U.K.; product launch planned for 2001

Read More

Chemokine receptor antagonists designed at the former SmithKline Beecham

Read More

Antimalarial agents with a 2,3-dioxabicyclo[3.3.1]nonane structure

Read More

Sagami patents new series of immunosuppressants acting on protein phosphatase

Read More

Nymox and Biophage establish collaborative agreement for antimicrobial treatments

Read More

Inhibitors of PDE4 with antiasthmatic effects identified at Fuji Photo Film

Read More

Recent Japanese patent covers naturally occurring antiinflammatory agents

Read More

N-type calcium channel blockers and their use claimed in recent patent

Read More

New antibacterial peptide discovered at Meiji Milk Products

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 10, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing